Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Slideshows

Catch up on the top stories in optometry during the week of May 5-May 9.

Takeaways from this week in optometry: May 5 - May 9

Videos

At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.

ARVO 2025: Rethinking centile growth curves in myopia management with Mark Bullimore, MCOptom, PhD

Articles

The first-in-class endothelin antagonist intravitreal implant aided in increasing ocular blood flow and improved both visual function and anatomic structure, according to the company.

ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma

The Early Detection of Vision Impairments for Children Act (EDVI), or HR 2527, would allow the federal government to award grants and cooperative agreements to eligible states and communities for children's vision care initiatives. 

Prevent Blindness voices support for reintroduction of EDVI Act

The leading source of breaking news, news analysis, and emerging research reports in optometry, Optometry Times® disseminates practical content by optometrists for optometrists that can be immediately applied to improve the clinical experience.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times | Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

Conference

Test

1rem

Meeting attendees take courses on and engage in discourse on the field’s latest challenges.

Optometrists sing to the tune of advocacy in 2024

Results from the first-in-human study of SpyGlass Pharma's bimatoprost-eluting IOL showed significant reduction in IOP and improved best-corrected distance visual acuity.

18-month data of IOL-mounted drug delivery platform shows impressive results in IOP, visual acuity

ASCRS

A contact lens unveiling, geographic atrophy management, and an eventful Merton C Flom Leadership Academy luncheon took center stage at last month's conference.

Top takeaways from the 2024 meeting of the American Academy of Optometry

American Academy of Optometry

CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.

CRU 2025: What eye care providers took home that is current, relevant, and useful

CRU Eye Symposium

Lindsell discusses promising retinal therapeutics, such as at-home therapies, gene therapy, and devices like the Valeda Light Delivery System (LumiThera), which uses photobiomodulation and shows early promise in preventing geographic atrophy altogether.

CIME 2025: Luke Lindsell, OD, MD, on bridging innovation and practical care in retinal disease

Controversies in Modern Eye Care

Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.

EnVision Summit 2025: What you missed in keratoconus, AI, and comanagement

EnVision Summit

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive management techniques, aiming to enhance patient outcomes in glaucoma care.

EyeCon 2024: Red flags, red herrings to look out for in glaucoma cases

EyeCon

LL-BMT1 is a sustained drug delivery approach via a 3D-printed, drug-eluting contact lens to be used in glaucoma care that successfully completed a Phase 2b clinical trial.

MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma

Glaucoma 360

Michael Belin, MD, weighs the ABCD and Amsler-Krumeich classifications and proposes ABCD progression displays as an effective modern alternative.

IKA 2024: ABCD versus Amsler-Krumeich classifications

International Keratoconus Academy Symposium

Essence Johnson, OD, FAAO, addressed the "State of optometry," at NOA 2023 in Fort Lauderdale, Florida.

NOA 2023: Dissecting the state of optometry

SECO 2025: Insightful discussions on light therapy, ptosis, and the view from behind the slit lamp

SECO

How OSD affects advanced technology IOLs 

Twin Cities Ocular Surface Disease Symposium

Vision Expo East 2023 will take place in New York, New York, on March 16-19 at the Javits Center. 

Vision Expo East 2023 preview: An agenda jam-packed with education, frame sales, and practice management tips

Vision Expo East

Charissa Lee, OD, MBA, FAAO; Ryan Corte, OD; Roxanne Achong-Coan OD, FAAO, FIAOMC, FSLS, Dip CCLRT; and Nishan Pressley, OD; give their insights on distinguishing the best candidates for contact lens wear.

Vision Expo East 2025: An exclusive Q&A on finding the right fit for dual, contact lens wear – Part 2

Optometric insights shine brighter than the lights on the Las Vegas Strip.

A dazzling Vision Expo West pairs showmanship with education and research

Vision Expo West